GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dimerix Ltd (OTCPK:SBMJF) » Definitions » YoY Rev. per Sh. Growth

SBMJF (Dimerix) YoY Rev. per Sh. Growth : 0.00% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Dimerix YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Dimerix's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was 0.00%.

Dimerix's Revenue per Share for the six months ended in Dec. 2023 was $0.00.

Dimerix YoY Rev. per Sh. Growth Historical Data

The historical data trend for Dimerix's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimerix YoY Rev. per Sh. Growth Chart

Dimerix Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dimerix Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Dimerix YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Dimerix's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Jun. 2023 )
=(Revenue per Share (A: Jun. 2023 )-Revenue per Share (A: Jun. 2022 ))/ | Revenue per Share (A: Jun. 2022 ) |
=(0-0)/ | 0 |
=N/A %

Dimerix's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=(Revenue per Share (Q: Dec. 2023 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dimerix YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Dimerix's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Dimerix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dimerix Ltd (OTCPK:SBMJF) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
ASX:LTP ASX:ALA ASX:OCC ASX:RAC ASX:EZZ ASX:PAR ASX:RCE ASX:NUZ ASX:AGN ASX:IMU VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
DXB:Australia
Address
425 Smith Street, Fitzroy, VIC, AUS, 3065
Website
https://www.dimerix.com
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Dimerix Headlines

From GuruFocus

DIMERIX's DMX-200 Posts Strong Results in Kidney Disease Trial

By Business Wire Business Wire • 07-29-2020